Education
About Us
Working with TipRanks
Follow Us
Cizzle Biotechnology Holdings PLC (GB:CIZ)
LSE:CIZ
Total Valuation
Cizzle Biotechnology Holdings PLC has a market cap or net worth of £6.14M. The enterprise value is 6.11M.
Market Cap£6.14M
Enterprise Value6.11M
Share Statistics
Cizzle Biotechnology Holdings PLC has 396,391,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding396,391,780
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Cizzle Biotechnology Holdings PLC’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1060.45%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-1060.45%
Return on Capital Employed (ROCE)-10.71
Revenue Per Employee0.00
Profits Per Employee-547.00K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cizzle Biotechnology Holdings PLC is ―. Cizzle Biotechnology Holdings PLC’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.07
Price to Fair Value0.07
Price to FCF-0.02
Price to Operating Cash Flow-17.73
PEG Ratio0.00
Income Statement
In the last 12 months, Cizzle Biotechnology Holdings PLC had revenue of 0.00 and earned -2.17K in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit0.00
Operating Income-878.00K
Pretax Income-2.19M
Net Income-2.17K
EBITDA0.00
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -331.12K and capital expenditures -2.00K, giving a free cash flow of -333.12K billion.
Operating Cash Flow-331.12K
Free Cash Flow-333.12K
Free Cash Flow per Share>-0.01
Dividends & Yields
Cizzle Biotechnology Holdings PLC pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change0.00%
50-Day Moving Average1.61
200-Day Moving Average1.58
Relative Strength Index (RSI)40.04
Average Volume (3m)1.23M
Important Dates
Cizzle Biotechnology Holdings PLC upcoming earnings date is May 6, 2026, TBA (Confirmed).
Last Earnings DateSep 30, 2025
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Cizzle Biotechnology Holdings PLC as a current ratio of 1.20, with Debt / Equity ratio of 0.00%
Current Ratio1.20
Quick Ratio1.20
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cizzle Biotechnology Holdings PLC has paid -21.00K in taxes.
Income Tax-21.00K
Effective Tax Rate<0.01
Enterprise Valuation
Cizzle Biotechnology Holdings PLC EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 1.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow1.00
EV to Operating Cash Flow1.00
Balance Sheet
Cizzle Biotechnology Holdings PLC has £182.00K in cash and marketable securities with £0.00 in debt, giving a net cash position of £32.00K billion.
Cash & Marketable Securities£182.00K
Total Debt£0.00
Net Cash£32.00K
Net Cash Per Share<£0.01
Tangible Book Value Per Share£0.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cizzle Biotechnology Holdings PLC is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―